Association between Atmospheric Fine Particulate Matter and Hospital Admissions for Chronic Obstructive Pulmonary Disease in Southwestern Taiwan: A Population-Based Study

Abstract

Objectives: This paper reports on the findings of a population-based study to evaluate the relationship between atmospheric fine particulate matter (PM2.5) levels and hospital admissions for chronic obstructive pulmonary disease (COPD) in southwestern Taiwan over a three-year period, 2008–2010. Methods: Data on hospital admissions for COPD and PM2.5 levels were obtained from the National Health Insurance Research database (NHIRD) and the Environmental Protection Administration from 2008 to 2010, respectively. The lag structure of relative risks (RRs) of hospital admissions for COPD was estimated using a Poisson regression model. Results: During the study period, the overall average hospitalization rate of COPD and mean 24-h average level of PM2.5 was 0.18% and 39.37 μg/m3, respectively. There were seasonal variations in PM2.5 concentrations in southwestern Taiwan, with higher PM2.5 concentrations in both spring (average: 48.54 μg/m3) and winter (49.96 μg/m3) than in summer (25.89 μg/m3) and autumn (33.37 μg/m3). Increased COPD admissions were significantly associated with PM2.5 in both spring (February–April) and winter (October–January), with the relative risks (RRs) for every 10 μg/m3 increase in PM2.5 being 1.25 (95% CI = 1.22–1.27) and 1.24 (95% CI = 1.23–1.26), respectively, at a lag zero days (i.e., no lag days). Lag effects on COPD admissions were observed for PM2.5, with the elevated RRs beginning at lag zero days and larger RRs estimates tending to occur at longer lags (up to six days, i.e., lag 0–5 days). Conclusions: In general, findings reveal an association between atmospheric fine particulate matter (PM2.5) and hospital admissions for COPD in southwestern Taiwan, especially during both spring and winter seasons.

Vitamin D protects against particles‐caused lung injury through induction of autophagy in an Nrf2‐dependent manner

“…Currently, it is a well‐known air pollutant threatening public health. Clinical studies reported that long‐term exposure to the particles associated with reduction in pulmonary function, exacerbation of chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD), and increased incidence and mortality of lung cancer . Epidemiological studies revealed an inverse relationship between the particles inhalation and human average life span .…”

Environmental Regulation, Foreign Direct Investment and Green Technological Progress—Evidence from Chinese Manufacturing Industries

“…The PM 2.5 concentration in Beijing during 2013 significantly exceeded the health standard suggested by the World Health Organization (WHO) [ 2 , 3 , 4 ], and has caused the total economic losses of 246.26 billion Yuan (approximately 1.1% of the national GDP) during 2007 [ 5 ]. Not only that, the serious air pollution in China caused significant public health impacts [ 6 , 7 ]. The Global Burden of Disease (GBD) study undertaken by Institute for Health Metrics and Evaluation and World Health Organization (WHO) linked over 3.2 million premature deaths to PM pollution in 2010, and roughly one-third (1.23 million) of the world’s estimated PM pollution-related premature deaths were in China [ 8 ].…”

Socioeconomic Drivers of PM2.5 in the Accumulation Phase of Air Pollution Episodes in the Yangtze River Delta of China

“…In particular, fine particulate matter (PM 2.5 ), a type of pollutant, has been verified to be unhealthy for humans and the living environment, as it can cause lung cancer, respiratory and cardiovascular diseases, affect transportation, as well as increase mortality [1,2,3,4]. Recently, PM 2.5 pollution has become the greatest environmental problem in China and is therefore attracting growing public concern.…”